Citigroup Inc reports 16.08% increase in ownership of ER4 / Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

DE ˙ DB ˙ US29089Q1058

6,70 € ↓ -0,51 (-7,07%)

2026-06-03
AKTIENPREIS

Security	DE:ER4 / Emergent BioSolutions Inc.
Institution	Citigroup Inc
Latest Disclosed Ownership	13,049 shares
Latest Disclosed Value	$ 108,306

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 13,049 shares of Emergent BioSolutions Inc. (DE:ER4) valued at $92,048 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 11,241 shares of Emergent BioSolutions Inc.. This represents a change in shares of 16.08% during the quarter. The current value of the position is $87,428 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-11	2026-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	13,049	1,808	16.08	108	-21.74	0.0000
2026-02-13	2025-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	11,241	7,329	187.35	139	305.88	0.0001
2025-11-10	2025-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	3,912	-30,277	-88.56	35	-84.40	0.0000
2025-08-11	2025-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	34,189	-52,995	-60.79	218	-48.46	0.0001
2025-05-12	2025-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	87,184	1,665	1.95	424	-48.23	0.0002
2025-02-12	2024-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	85,519	45,881	115.75	818	147.58	0.0005
2024-11-12	2024-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	39,638	17,707	80.74	331	121.48	0.0002
2024-08-12	2024-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	21,931	9,564	77.33	150	380.65	0.0001
2024-05-10	2024-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	12,367	4,783	63.07	31	72.22	0.0000
2024-02-09	2023-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	7,584	-7,484	-49.67	18	-64.71	0.0000
2023-12-06	2023-09-30	13F/A-1	EMERGENT BIOSOLUTIONS	COM	29089Q105	15,068	-178,922	-92.23	51	-96.42	0.0000
2023-11-09	2023-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	15,068	-178,922		51		0.0000
2023-08-10	2023-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	193,990	-133,369	-40.74	1,426	-57.98	0.0009
2023-05-11	2023-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	327,359	118,396	56.66	3,391	37.45	0.0024
2023-02-09	2022-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	208,963	-25,358	-10.82	2,468	-49.84	0.0020
2022-11-10	2022-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	234,321	84,699	56.61	4,918	5.90	0.0035
2022-08-10	2022-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	149,622	84,482	129.69	4,644	73.61	0.0035
2022-05-12	2022-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	65,140	-71,189	-52.22	2,675	-54.86	0.0016
2022-02-10	2021-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	136,329	95,772	236.14	5,926	191.92	0.0032
2021-11-10	2021-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	40,557	-61,001	-60.07	2,030	-68.27	0.0012
2021-08-10	2021-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	101,558	46,904	85.82	6,397	25.97	0.0038
2021-05-13	2021-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	54,654	26,084	91.30	5,078	98.36	0.0033
2021-02-11	2020-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	28,570	11,811	70.48	2,560	47.89	0.0015
2020-11-12	2020-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	16,759	-95,537	-85.08	1,731	-80.51	0.0011
2020-08-12	2020-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	112,296	79,054	237.81	8,880	361.54	0.0069
2020-05-12	2020-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	33,242	-236	-0.70	1,924	6.53	0.0017
2020-02-12	2019-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	33,478	-24,223	-41.98	1,806	-40.14	0.0013
2019-11-08	2019-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	57,701	13,036	29.19	3,017	39.81	0.0024
2019-08-12	2019-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	44,665	15,307	52.14	2,158	45.52	0.0017
2019-05-13	2019-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	29,358	-31,479	-51.74	1,483	-58.89	0.0014
2019-02-12	2018-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	60,837	33,424	121.93	3,607	99.83	0.0037
2018-11-13	2018-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	27,413	19,894	264.58	1,805	375.00	0.0016
2018-08-10	2018-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	7,519	-31,377	-80.67	380	-81.44	0.0003
2018-05-11	2018-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	38,896	-8,378	-17.72	2,047	-6.79	0.0017
2018-02-12	2017-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	47,274	-6,502	-12.09	2,196	0.92	0.0018
2017-11-13	2017-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	53,776	-7,158	-11.75	2,176	5.27	0.0018
2017-08-11	2017-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	60,934	6,967	12.91	2,067	31.91	0.0019
2017-05-12	2017-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	53,967	-61,669	-53.33	1,567	-58.73	0.0014
2017-02-10	2016-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	115,636	89,298	339.05	3,797	357.47	0.0034
2016-11-10	2016-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	26,338	16,039	155.73	830	186.21	0.0008
2016-08-12	2016-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	10,299	-12,320	-54.47	290	-64.68	0.0003
2016-05-13	2016-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	22,619	20,017	769.29	821	689.42	0.0009
2016-02-12	2015-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,602	-134	-4.90	104	33.33	0.0001
2015-11-13	2015-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,736	-140	-4.87	78	-17.89	0.0001
2015-08-13	2015-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,876	-7,372	-71.94	95	-67.80	0.0001
2015-05-14	2015-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	10,248	8,685	555.66	295	602.38	0.0003
2015-02-17	2014-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,563	-3,260	-67.59	42	-59.22	0.0000
2014-11-14	2014-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,823	3	0.06	103	-4.63	0.0001
2014-08-14	2014-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,820	1,513	45.75	108	28.57	0.0001
2014-05-15	2014-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	3,307	-6,809	-67.31	84	-63.79	0.0001
2014-02-14	2013-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	10,116	5,998	145.65	232	197.44	0.0002
2013-11-14	2013-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,118	-5,768	-58.35	78	-45.45	0.0001
2013-08-14	2013-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	9,886	9,886		143		0.0001

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.